The Combination Of Keytruda Plus Lenvima Improves Survival In Advanced Endometrial Cancer
There was a statistically significant and clinically meaningful improvement in overall survival, progression free survival, and objective response rate compared to chemotherapy in the phase 3 KEYNOTE-775/Study 309 Trial.